Mirae Asset Global Investments Co., Ltd. Cassava Sciences Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 16,475 shares of SAVA stock, worth $166,068. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,475
Previous 17,893
7.92%
Holding current value
$166,068
Previous $402,000
16.92%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SAVA
# of Institutions
171Shares Held
11.3MCall Options Held
1.61MPut Options Held
1.43M-
Black Rock Inc. New York, NY3.05MShares$30.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.36MShares$23.8 Million0.0% of portfolio
-
State Street Corp Boston, MA1.09MShares$11 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA902KShares$9.09 Million0.0% of portfolio
-
Gallacher Capital Management LLC Lone Tree, CO585KShares$5.9 Million6.03% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $404M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...